...
机译:高风险MDS高风险MDS和AML AML接受低甲基化试剂的患者侵袭性真菌感染的风险
Department of Pharmacy and Clinical ServicesHackensack University Medical CenterHackensack New;
Department of PharmacyHospital of the University of PennsylvaniaPhiladelphia Pennsylvania USA;
Department of PharmacyHospital of the University of PennsylvaniaPhiladelphia Pennsylvania USA;
Division of Infectious Diseases Department of MedicinePerelman School of Medicine at the;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Infectious Diseases Department of MedicinePerelman School of Medicine at the;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
Division of Hematology‐Oncology/Department of MedicineUniversity of PennsylvaniaPhiladelphia;
机译:高风险MDS高风险MDS和AML AML接受低甲基化试剂的患者侵袭性真菌感染的风险
机译:用低甲基化剂治疗的AML和MDS老年患者的感染风险
机译:用阿扎胞苷治疗的AML / MDS患者的侵袭性真菌感染:是否值得考虑预防真菌的风险?
机译:患者护理对侵袭性装置对医疗相关感染风险的影响
机译:影响移植患者侵袭性真菌感染风险的行为因素。
机译:用低甲基化剂治疗的AML和MDS老年患者的感染风险
机译:单一代理人Talacotuzumab表现出有限的疗效,但老年高风险MDS或AML患者的毒性相当大的毒性,未发生甲基化剂